On September 14th, RudaCure held a briefing session for actionnaires to provide an update on recent achievements and current business activities, and to foster mutual understanding and continued cooperation.
Nous remercions les actionnaires présents, and we will maintain our actionnaire-first management approach sur la base de the information discussed and shared on the day, while doing our utmost to achieve our développement de médicaments goals.
We hope you will continue to watch RudaCure grow and cheer us on.
Thank you.